Ultrasonic gene and drug delivery to the cardiovascular system

Advanced Drug Delivery Reviews

Volumn 60, Issue 10, 2008, Pages 1177-1192

  Mayer, Christian R ^a   Bekeredjian, Raffi ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Cardiovascular system; Drug delivery; Gene therapy; Heart; Microbubble; Ultrasound

Indexed keywords

CARDIOVASCULAR SYSTEM; CELL MEMBRANES; DRUG DELIVERY; ECHOCARDIOGRAPHY; MECHANICAL PERMEABILITY; ULTRASONICS;

GENE THERAPY; MICROBUBBLE; MYOCARDIAL CONTRAST ECHOCARDIOGRAPHY; REFILL KINETICS;

GENES;

ADENOVIRUS VECTOR; AVI 4126; BETA ADRENERGIC RECEPTOR KINASE; BETA GALACTOSIDASE; CHLORAMPHENICOL; HYPOXIA INDUCIBLE FACTOR 1ALPHA; LENTIVIRUS VECTOR; LUCIFERASE; MEMBRANE PROTEIN; NAKED DNA; PARVOVIRUS VECTOR; PERFLUTREN; PHOSPHOLAMBAN; PLACEBO; PLASMID DNA; PROTEIN S100A1; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT SCATTER FACTOR; RECOMBINANT VASCULOTROPIN; RETEPLASE; RETROVIRUS VECTOR; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; SMALL INTERFERING RNA; STREPTOKINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TISSUE PLASMINOGEN ACTIVATOR; TUMOR NECROSIS FACTOR ALPHA; UROKINASE; VASCULOTROPIN 121; VASCULOTROPIN 165;

ANGINA PECTORIS; ANGIOGENESIS; BLEEDING; CARDIOVASCULAR SYSTEM; CELL MEMBRANE PERMEABILITY; CLINICAL TRIAL; CONTRAST ECHOCARDIOGRAPHY; CORONARY ARTERY DISEASE; DRUG DELIVERY SYSTEM; GENE THERAPY; HEART FAILURE; HEART MUSCLE ISCHEMIA; HUMAN; INFLAMMATION; MICROBUBBLE; NONHUMAN; PRIORITY JOURNAL; REVIEW; RNA INTERFERENCE; THROMBOSIS; ULTRASOUND; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; CARDIOVASCULAR DISEASES; DRUG DELIVERY SYSTEMS; GENE THERAPY; GENE TRANSFER TECHNIQUES; HUMANS; THROMBOSIS; ULTRASONICS;

EID: 44149103793     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addr.2008.03.004     Document Type: Review

References (126)

1. Rosamond W., Flegal K., Friday G., Furie K., Go A., Greenlund K., Haase N., Ho M., Howard V., Kissela B., Kittner S., Lloyd-Jones D., McDermott M., Meigs J., Moy C., Nichol G., O'Donnell C.J., Roger V., Rumsfeld J., Sorlie P., Steinberger J., Thom T., Wasserthiel-Smoller S., and Hong Y. Heart disease and stroke statistics - 2007 update: A report from the American heart association statistics committee and stroke statistics subcommittee. Circulation 115 (2007) e69-e171
2. Leal J., Luengo-Fernandez R., Gray A., Petersen S., and Rayner M. Economic burden of cardiovascular diseases in the enlarged European union. Eur. Heart J. 27 (2006) 1610-1619
3. Leong-Poi H., Le E., Rim S.J., Sakuma T., Kaul S., and Wei K. Quantification of myocardial perfusion and determination of coronary stenosis severity during hyperemia using real-time myocardial contrast echocardiography. J. Am. Soc. Echocardiogr. 14 (2001) 1173-1182
4. Unger E.C., Hersh E., Vannan M., Matsunaga T.O., and McCreery T. Local drug and gene delivery through microbubbles. Prog. Cardiovasc. Dis. 44 (2001) 45-54
5. Unger E.C., Matsunaga T.O., McCreery T., Schumann P., Sweitzer R., and Quigley R. Therapeutic applications of microbubbles. Eur. J. Radiol. 42 (2002) 160-168
6. Miller M.W. Gene transfection and drug delivery. Ultrasound Med. Biol. 26. Suppl. 1 (2000) S59-S62
7. Bekeredjian R., Grayburn P.A., and Shohet R.V. Use of ultrasound contrast agents for gene or drug delivery in cardiovascular medicine. J. Am. Coll. Cardiol. 45 (2005) 329-335
8. Jones J.M., and Koch W.J. Gene therapy approaches to cardiovascular disease. Methods Mol. Med. 112 (2005) 15-35
9. Grundy S.M., Pasternak R., Greenland P., Smith Jr. S., and Fuster V. Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: A statement for healthcare professionals from the American heart association and the American college of cardiology. Circulation 100 (1999) 1481-1492
10. Takeshita S., Zheng L.P., Brogi E., Kearney M., Pu L.Q., Bunting S., Ferrara N., Symes J.F., and Isner J.M. Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. J. Clin. Invest. 93 (1994) 662-670
11. Isner J.M., Pieczek A., Schainfeld R., Blair R., Haley L., Asahara T., Rosenfield K., Razvi S., Walsh K., and Symes J.F. Clinical evidence of angiogenesis after arterial gene transfer of phvegf165 in patient with ischaemic limb. Lancet 348 (1996) 370-374
12. Baumgartner I., Pieczek A., Manor O., Blair R., Kearney M., Walsh K., and Isner J.M. Constitutive expression of phvegf165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation 97 (1998) 1114-1123
13. Losordo D.W., Vale P.R., Symes J.F., Dunnington C.H., Esakof D.D., Maysky M., Ashare A.B., Lathi K., and Isner J.M. Gene therapy for myocardial angiogenesis: Initial clinical results with direct myocardial injection of phvegf165 as sole therapy for myocardial ischemia. Circulation 98 (1998) 2800-2804
14. Kastrup J., Jorgensen E., Ruck A., Tagil K., Glogar D., Ruzyllo W., Botker H.E., Dudek D., Drvota V., Hesse B., Thuesen L., Blomberg P., Gyongyosi M., and Sylven C. Direct intramyocardial plasmid vascular endothelial growth factor-a165 gene therapy in patients with stable severe angina pectoris a randomized double-blind placebo-controlled study: The euroinject one trial. J. Am. Coll. Cardiol. 45 (2005) 982-988
15. Reilly J.P., Grise M.A., Fortuin F.D., Vale P.R., Schaer G.L., Lopez J., van Camp J.R., Henry T., Richenbacher W.E., Losordo D.W., Schatz R.A., and Isner J.M. Long-term (2-year) clinical events following transthoracic intramyocardial gene transfer of vegf-2 in no-option patients. J. Interv. Cardiol. 18 (2005) 27-31
16. Dor Y., Djonov V., Abramovitch R., Itin A., Fishman G.I., Carmeliet P., Goelman G., and Keshet E. Conditional switching of vegf provides new insights into adult neovascularization and pro-angiogenic therapy. Embo J. 21 (2002) 1939-1947
17. Yanagisawa-Miwa A., Uchida Y., Nakamura F., Tomaru T., Kido H., Kamijo T., Sugimoto T., Kaji K., Utsuyama M., Kurashima C., et al. Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor. Science 257 (1992) 1401-1403
18. Grines C.L., Watkins M.W., Mahmarian J.J., Iskandrian A.E., Rade J.J., Marrott P., Pratt C., and Kleiman N. A randomized, double-blind, placebo-controlled trial of ad5fgf-4 gene therapy and its effect on myocardial perfusion in patients with stable angina. J. Am. Coll. Cardiol. 42 (2003) 1339-1347
19. Udelson J.E., Dilsizian V., Laham R.J., Chronos N., Vansant J., Blais M., Galt J.R., Pike M., Yoshizawa C., and Simons M. Therapeutic angiogenesis with recombinant fibroblast growth factor-2 improves stress and rest myocardial perfusion abnormalities in patients with severe symptomatic chronic coronary artery disease. Circulation 102 (2000) 1605-1610
20. Azuma J., Taniyama Y., Takeya Y., Iekushi K., Aoki M., Dosaka N., Matsumoto K., Nakamura T., Ogihara T., and Morishita R. Angiogenic and antifibrotic actions of hepatocyte growth factor improve cardiac dysfunction in porcine ischemic cardiomyopathy. Gene Ther. 13 (2006) 1206-1213
21. Morishita R., Aoki M., Hashiya N., Makino H., Yamasaki K., Azuma J., Sawa Y., Matsuda H., Kaneda Y., and Ogihara T. Safety evaluation of clinical gene therapy using hepatocyte growth factor to treat peripheral arterial disease. Hypertension 44 (2004) 203-209
22. Morishita R., Nakamura S., Hayashi S., Taniyama Y., Moriguchi A., Nagano T., Taiji M., Noguchi H., Takeshita S., Matsumoto K., Nakamura T., Higaki J., and Ogihara T. Therapeutic angiogenesis induced by human recombinant hepatocyte growth factor in rabbit hind limb ischemia model as cytokine supplement therapy. Hypertension 33 (1999) 1379-1384
23. Manalo D.J., Rowan A., Lavoie T., Natarajan L., Kelly B.D., Ye S.Q., Garcia J.G., and Semenza G.L. Transcriptional regulation of vascular endothelial cell responses to hypoxia by hif-1. Blood 105 (2005) 659-669
24. Ke Q., and Costa M. Hypoxia-inducible factor-1 (hif-1). Mol. Pharmacol. 70 (2006) 1469-1480
25. Hewitson K.S., and Schofield C.J. The hif pathway as a therapeutic target. Drug Discov. Today 9 (2004) 704-711
26. Vincent K.A., Shyu K.G., Luo Y., Magner M., Tio R.A., Jiang C., Goldberg M.A., Akita G.Y., Gregory R.J., and Isner J.M. Angiogenesis is induced in a rabbit model of hindlimb ischemia by naked DNA encoding an hif-1alpha/vp16 hybrid transcription factor. Circulation 102 (2000) 2255-2261
27. Elson D.A., Thurston G., Huang L.E., Ginzinger D.G., McDonald D.M., Johnson R.S., and Arbeit J.M. Induction of hypervascularity without leakage or inflammation in transgenic mice overexpressing hypoxia-inducible factor-1alpha. Genes Dev. 15 (2001) 2520-2532
28. Pajusola K., Kunnapuu J., Vuorikoski S., Soronen J., Andre H., Pereira T., Korpisalo P., Yla-Herttuala S., Poellinger L., and Alitalo K. Stabilized hif-1alpha is superior to vegf for angiogenesis in skeletal muscle via adeno-associated virus gene transfer. Faseb J. 19 (2005) 1365-1367
29. Tevaearai H.T., Walton G.B., and Koch W.J. [gene therapy and benefits in modulating of system beta-adrenergic in cardiac insufficiency]. Rev. Med. Suisse. Romande. 122 (2002) 149-153
30. Gwathmey J.K., Copelas L., MacKinnon R., Schoen F.J., Feldman M.D., Grossman W., and Morgan J.P. Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure. Circ. Res. 61 (1987) 70-76
31. Davies C.H., Davia K., Bennett J.G., Pepper J.R., Poole-Wilson P.A., and Harding S.E. Reduced contraction and altered frequency response of isolated ventricular myocytes from patients with heart failure. Circulation 92 (1995) 2540-2549
32. Miyamoto M.I., del Monte F., Schmidt U., DiSalvo T.S., Kang Z.B., Matsui T., Guerrero J.L., Gwathmey J.K., Rosenzweig A., and Hajjar R.J. Adenoviral gene transfer of serca2a improves left-ventricular function in aortic-banded rats in transition to heart failure. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 793-798
33. del Monte F., Williams E., Lebeche D., Schmidt U., Rosenzweig A., Gwathmey J.K., Lewandowski E.D., and Hajjar R.J. Improvement in survival and cardiac metabolism after gene transfer of sarcoplasmic reticulum ca(2+)-atpase in a rat model of heart failure. Circulation 104 (2001) 1424-1429
34. Hoshijima M., Ikeda Y., Iwanaga Y., Minamisawa S., Date M.O., Gu Y., Iwatate M., Li M., Wang L., Wilson J.M., Wang Y., Ross Jr. J., and Chien K.R. Chronic suppression of heart-failure progression by a pseudophosphorylated mutant of phospholamban via in vivo cardiac raav gene delivery. Nat. Med. 8 (2002) 864-871
35. Iwanaga Y., Hoshijima M., Gu Y., Iwatate M., Dieterle T., Ikeda Y., Date M.O., Chrast J., Matsuzaki M., Peterson K.L., Chien K.R., and Ross Jr. J. Chronic phospholamban inhibition prevents progressive cardiac dysfunction and pathological remodeling after infarction in rats. J. Clin. Invest. 113 (2004) 727-736
36. Braz J.C., Gregory K., Pathak A., Zhao W., Sahin B., Klevitsky R., Kimball T.F., Lorenz J.N., Nairn A.C., Liggett S.B., Bodi I., Wang S., Schwartz A., Lakatta E.G., DePaoli-Roach A.A., Robbins J., Hewett T.E., Bibb J.A., Westfall M.V., Kranias E.G., and Molkentin J.D. Pkc-alpha regulates cardiac contractility and propensity toward heart failure. Nat. Med. 10 (2004) 248-254
37. Pathak A., del Monte F., Zhao W., Schultz J.E., Lorenz J.N., Bodi I., Weiser D., Hahn H., Carr A.N., Syed F., Mavila N., Jha L., Qian J., Marreez Y., Chen G., McGraw D.W., Heist E.K., Guerrero J.L., DePaoli-Roach A.A., Hajjar R.J., and Kranias E.G. Enhancement of cardiac function and suppression of heart failure progression by inhibition of protein phosphatase 1. Circ. Res. 96 (2005) 756-766
38. Remppis A., Greten T., Schafer B.W., Hunziker P., Erne P., Katus H.A., and Heizmann C.W. Altered expression of the ca(2+)-binding protein s100a1 in human cardiomyopathy. Biochim. Biophys. Acta 1313 (1996) 253-257
39. Most P., Pleger S.T., Volkers M., Heidt B., Boerries M., Weichenhan D., Loffler E., Janssen P.M., Eckhart A.D., Martini J., Williams M.L., Katus H.A., Remppis A., and Koch W.J. Cardiac adenoviral s100a1 gene delivery rescues failing myocardium. J. Clin. Invest. 114 (2004) 1550-1563
40. Squadrito F., Deodato B., Squadrito G., Seminara P., Passaniti M., Venuti F.S., Giacca M., Minutoli L., Adamo E.B., Bellomo M., Marini R., Galeano M., Marini H., and Altavilla D. Gene transfer of ikappabalpha limits infarct size in a mouse model of myocardial ischemia-reperfusion injury. Lab. Invest. 83 (2003) 1097-1104
41. Chatterjee S., Stewart A.S., Bish L.T., Jayasankar V., Kim E.M., Pirolli T., Burdick J., Woo Y.J., Gardner T.J., and Sweeney H.L. Viral gene transfer of the antiapoptotic factor bcl-2 protects against chronic postischemic heart failure. Circulation 106 (2002) I212-I217
42. Hikoso S., Ikeda Y., Yamaguchi O., Takeda T., Higuchi Y., Hirotani S., Kashiwase K., Yamada M., Asahi M., Matsumura Y., Nishida K., Matsuzaki M., Hori M., and Otsu K. Progression of heart failure was suppressed by inhibition of apoptosis signal-regulating kinase 1 via transcoronary gene transfer. J. Am. Coll. Cardiol. 50 (2007) 453-462
43. Hammond H.K. Adenylyl cyclase gene transfer in heart failure. Ann. N. Y. Acad. Sci. 1080 (2006) 426-436
44. Choi J.S., Kim K.B., Han W., Kim D.S., Park J.S., Lee J.J., and Lee D.S. Efficacy of therapeutic angiogenesis by intramyocardial injection of pck-vegf165 in pigs. Ann. Thorac. Surg. 82 (2006) 679-686
45. Von Bibra H., Voigt J.U., Froman M., Bone D., Wranne B., and Juhlin-Dannfeldt A. Interaction of microbubbles with ultrasound. Echocardiography 16 (1999) 733-741
46. Skyba D.M., Price R.J., Linka A.Z., Skalak T.C., and Kaul S. Direct in vivo visualization of intravascular destruction of microbubbles by ultrasound and its local effects on tissue. Circulation 98 (1998) 290-293
47. Seemann S., Hauff P., Schultze-Mosgau M., Lehmann C., and Reszka R. Pharmaceutical evaluation of gas-filled microparticles as gene delivery system. Pharm. Res. 19 (2002) 250-257
48. Huber P.E., and Pfisterer P. In vitro and in vivo transfection of plasmid DNA in the dunning prostate tumor r3327-at1 is enhanced by focused ultrasound. Gene Ther. 7 (2000) 1516-1525
49. Kheirolomoom A., Dayton P.A., Lum A.F., Little E., Paoli E.E., Zheng H., and Ferrara K.W. Acoustically-active microbubbles conjugated to liposomes: Characterization of a proposed drug delivery vehicle. J. Control. Release 118 (2007) 275-284
50. Lum A.F., Borden M.A., Dayton P.A., Kruse D.E., Simon S.I., and Ferrara K.W. Ultrasound radiation force enables targeted deposition of model drug carriers loaded on microbubbles. J. Control. Release 111 (2006) 128-134
51. Rychak J.J., Lindner J.R., Ley K., and Klibanov A.L. Deformable gas-filled microbubbles targeted to p-selectin. J. Control. Release 114 (2006) 288-299
52. Martin M.J., Chung E.M., Goodall A.H., Della Martina A., Ramnarine K.V., Fan L., Hainsworth S.V., Naylor A.R., and Evans D.H. Enhanced detection of thromboemboli with the use of targeted microbubbles. Stroke 38 (2007) 2726-2732
53. Alonso A., Della Martina A., Stroick M., Fatar M., Griebe M., Pochon S., Schneider M., Hennerici M., Allemann E., and Meairs S. Molecular imaging of human thrombus with novel abciximab immunobubbles and ultrasound. Stroke 38 (2007) 1508-1514
54. Tiukinhoy S.D., Khan A.A., Huang S., Klegerman M.E., MacDonald R.C., and McPherson D.D. Novel echogenic drug-immunoliposomes for drug delivery. Invest. Radiol. 39 (2004) 104-110
55. Bekeredjian R., Bohris C., Hansen A., Katus H.A., Kuecherer H.F., and Hardt S.E. Impact of microbubbles on shock wave-mediated DNA uptake in cells in vitro. Ultrasound Med. Biol. 33 (2007) 743-750
56. Kondo I., Ohmori K., Oshita A., Takeuchi H., Fuke S., Shinomiya K., Noma T., Namba T., and Kohno M. Treatment of acute myocardial infarction by hepatocyte growth factor gene transfer: The first demonstration of myocardial transfer of a "functional" gene using ultrasonic microbubble destruction. J. Am. Coll. Cardiol. 44 (2004) 644-653
57. Bekeredjian R., Chen S., Frenkel P.A., Grayburn P.A., and Shohet R.V. Ultrasound-targeted microbubble destruction can repeatedly direct highly specific plasmid expression to the heart. Circulation 108 (2003) 1022-1026
58. Korpanty G., Chen S., Shohet R.V., Ding J., Yang B., Frenkel P.A., and Grayburn P.A. Targeting of vegf-mediated angiogenesis to rat myocardium using ultrasonic destruction of microbubbles. Gene Ther. 12 (2005) 1305-1312
59. Chen S., Shohet R.V., Bekeredjian R., Frenkel P., and Grayburn P.A. Optimization of ultrasound parameters for cardiac gene delivery of adenoviral or plasmid deoxyribonucleic acid by ultrasound-targeted microbubble destruction. J. Am. Coll. Cardiol. 42 (2003) 301-308
60. Frenkel P.A., Chen S., Thai T., Shohet R.V., and Grayburn P.A. DNA-loaded albumin microbubbles enhance ultrasound-mediated transfection in vitro. Ultrasound Med. Biol. 28 (2002) 817-822
61. Taniyama Y., Tachibana K., Hiraoka K., Namba T., Yamasaki K., Hashiya N., Aoki M., Ogihara T., Yasufumi K., and Morishita R. Local delivery of plasmid DNA into rat carotid artery using ultrasound. Circulation 105 (2002) 1233-1239
62. Taniyama Y., Tachibana K., Hiraoka K., Aoki M., Yamamoto S., Matsumoto K., Nakamura T., Ogihara T., Kaneda Y., and Morishita R. Development of safe and efficient novel nonviral gene transfer using ultrasound: enhancement of transfection efficiency of naked plasmid DNA in skeletal muscle. Gene Ther. 9 (2002) 372-380
63. Christiansen J.P., French B.A., Klibanov A.L., Kaul S., and Lindner J.R. Targeted tissue transfection with ultrasound destruction of plasmid-bearing cationic microbubbles. Ultrasound Med. Biol. 29 (2003) 1759-1767
64. Raake P.W., Hinkel R., Muller S., Delker S., Kreuzpointner R., Kupatt C., Katus H.A., Kleinschmidt J.A., Boekstegers P., and Muller O.J. Cardio-specific long-term gene expression in a porcine model after selective pressure-regulated retroinfusion of adeno-associated viral (aav) vectors. Gene Ther. 15 (2007) 7-12
65. Shohet R.V., Chen S., Zhou Y.T., Wang Z., Meidell R.S., Unger R.H., and Grayburn P.A. Echocardiographic destruction of albumin microbubbles directs gene delivery to the myocardium. Circulation 101 (2000) 2554-2556
66. Carter P.J., and Samulski R.J. Adeno-associated viral vectors as gene delivery vehicles. Int. J. Mol. Med. 6 (2000) 17-27
67. Muller O.J., Katus H.A., and Bekeredjian R. Targeting the heart with gene therapy-optimized gene delivery methods. Cardiovasc. Res. 73 (2007) 453-462
68. Bonci D., Cittadini A., Latronico M.V., Borello U., Aycock J.K., Drusco A., Innocenzi A., Follenzi A., Lavitrano M., Monti M.G., Ross Jr. J., Naldini L., Peschle C., Cossu G., and Condorelli G. 'Advanced' generation lentiviruses as efficient vectors for cardiomyocyte gene transduction in vitro and in vivo. Gene Ther. 10 (2003) 630-636
69. Inagaki H., Suzuki J., Ogawa M., Taniyama Y., Morishita R., and Isobe M. Ultrasound-microbubble-mediated nf-kappab decoy transfection attenuates neointimal formation after arterial injury in mice. J. Vasc. Res. 43 (2006) 12-18
70. Hashiya N., Aoki M., Tachibana K., Taniyama Y., Yamasaki K., Hiraoka K., Makino H., Yasufumi K., Ogihara T., and Morishita R. Local delivery of e2f decoy oligodeoxynucleotides using ultrasound with microbubble agent (optison) inhibits intimal hyperplasia after balloon injury in rat carotid artery model. Biochem. Biophys. Res. Commun. 317 (2004) 508-514
71. Porter T.R., Xie F., Knapp D., Iversen P., Marky L.A., Tsutsui J.M., Maiti S., Lof J., Radio S.J., and Kipshidze N. Targeted vascular delivery of antisense molecules using intravenous microbubbles. Cardiovasc. Revasc. Med. 7 (2006) 25-33
72. Mukherjee D., Wong J., Griffin B., Ellis S.G., Porter T., Sen S., and Thomas J.D. Ten-fold augmentation of endothelial uptake of vascular endothelial growth factor with ultrasound after systemic administration. J. Am. Coll. Cardiol. 35 (2000) 1678-1686
73. Iwasaki M., Adachi Y., Nishiue T., Minamino K., Suzuki Y., Zhang Y., Nakano K., Koike Y., Wang J., Mukaide H., Taketani S., Yuasa F., Tsubouchi H., Gohda E., Iwasaka T., and Ikehara S. Hepatocyte growth factor delivered by ultrasound-mediated destruction of microbubbles induces proliferation of cardiomyocytes and amelioration of left ventricular contractile function in doxorubicin-induced cardiomyopathy. Stem Cells 23 (2005) 1589-1597
74. Bekeredjian R., Kroll R.D., Fein E., Tinkov S., Coester C., Winter G., Katus H.A., and Kulaksiz H. Ultrasound targeted microbubble destruction increases capillary permeability in hepatomas. Ultrasound Med. Biol. 33 (2007) 1592-1598
75. Rapoport N., Gao Z., and Kennedy A. Multifunctional nanoparticles for combining ultrasonic tumor imaging and targeted chemotherapy. J. Natl. Cancer. Inst. 99 (2007) 1095-1106
76. Postema M., Bouakaz A., ten Cate F.J., Schmitz G., de Jong N., and van Wamel A. Nitric oxide delivery by ultrasonic cracking: Some limitations. Ultrasonics 44 Suppl 1 (2006) e109-e113
77. Kim H.J., Greenleaf J.F., Kinnick R.R., Bronk J.T., and Bolander M.E. Ultrasound-mediated transfection of mammalian cells. Hum. Gene Ther. 7 (1996) 1339-1346
78. Koch S., Pohl P., Cobet U., and Rainov N.G. Ultrasound enhancement of liposome-mediated cell transfection is caused by cavitation effects. Ultrasound Med. Biol. 26 (2000) 897-903
79. Lawrie A., Brisken A.F., Francis S.E., Cumberland D.C., Crossman D.C., and Newman C.M. Microbubble-enhanced ultrasound for vascular gene delivery. Gene Ther. 7 (2000) 2023-2027
80. Wei K., Skyba D.M., Firschke C., Jayaweera A.R., Lindner J.R., and Kaul S. Interactions between microbubbles and ultrasound: In vitro and in vivo observations. J. Am. Coll. Cardiol. 29 (1997) 1081-1088
81. Tsunoda S., Mazda O., Oda Y., Iida Y., Akabame S., Kishida T., Shin-Ya M., Asada H., Gojo S., Imanishi J., Matsubara H., and Yoshikawa T. Sonoporation using microbubble br14 promotes pdna/sirna transduction to murine heart. Biochem. Biophys. Res. Commun. 336 (2005) 118-127
82. Teupe C., Richter S., Fisslthaler B., Randriamboavonjy V., Ihling C., Fleming I., Busse R., Zeiher A.M., and Dimmeler S. Vascular gene transfer of phosphomimetic endothelial nitric oxide synthase (s1177d) using ultrasound-enhanced destruction of plasmid-loaded microbubbles improves vasoreactivity. Circulation 105 (2002) 1104-1109
83. Vannan M., McCreery T., Li P., Han Z., Unger E., Kuersten B., Nabel E., and Rajagopalan S. Ultrasound-mediated transfection of canine myocardium by intravenous administration of cationic microbubble-linked plasmid DNA. J. Am. Soc. Echocardiogr. 15 (2002) 214-218
84. Pislaru S.V., Pislaru C., Kinnick R.R., Singh R., Gulati R., Greenleaf J.F., and Simari R.D. Optimization of ultrasound-mediated gene transfer: Comparison of contrast agents and ultrasound modalities. Eur. Heart J. 24 (2003) 1690-1698
85. Li T., Tachibana K., and Kuroki M. Gene transfer with echo-enhanced contrast agents: Comparison between albunex, optison, and levovist in mice-initial results. Radiology 229 (2003) 423-428
86. Lu Q.L., Liang H.D., Partridge T., and Blomley M.J. Microbubble ultrasound improves the efficiency of gene transduction in skeletal muscle in vivo with reduced tissue damage. Gene Ther. 10 (2003) 396-405
87. Wang X., Liang H.D., Dong B., Lu Q.L., and Blomley M.J. Gene transfer with microbubble ultrasound and plasmid DNA into skeletal muscle of mice: Comparison between commercially available microbubble contrast agents. Radiology 237 (2005) 224-229
88. Kipshidze N.N., Porter T.R., Dangas G., Yazdi H., Tio F., Xie F., Hellinga D., Fournadjiev J., Wolfram R., Seabron R., Waksman R., Abizaid A., Roubin G., Iyer S., Leon M.B., Moses J.W., and Iversen P. Systemic targeted delivery of antisense with perflourobutane gas microbubble carrier reduced neointimal formation in the porcine coronary restenosis model. Cardiovasc. Radiat. Med. 4 (2003) 152-159
89. Erikson J.M., Freeman G.L., and Chandrasekar B. Ultrasound-targeted antisense oligonucleotide attenuates ischemia/reperfusion-induced myocardial tumor necrosis factor-alpha. J. Mol. Cell. Cardiol. 35 (2003) 119-130
90. Akowuah E.F., Gray C., Lawrie A., Sheridan P.J., Su C.H., Bettinger T., Brisken A.F., Gunn J., Crossman D.C., Francis S.E., Baker A.H., and Newman C.M. Ultrasound-mediated delivery of timp-3 plasmid DNA into saphenous vein leads to increased lumen size in a porcine interposition graft model. Gene Ther. 12 (2005) 1154-1157
91. Zhigang W., Zhiyu L., Haitao R., Hong R., Qunxia Z., Ailong H., Qi L., Chunjing Z., Hailin T., Lin G., Mingli P., and Shiyu P. Ultrasound-mediated microbubble destruction enhances vegf gene delivery to the infarcted myocardium in rats. Clin. Imaging 28 (2004) 395-398
92. Leong-Poi H., Kuliszewski M.A., Lekas M., Sibbald M., Teichert-Kuliszewska K., Klibanov A.L., Stewart D.J., and Lindner J.R. Therapeutic arteriogenesis by ultrasound-mediated vegf165 plasmid gene delivery to chronically ischemic skeletal muscle. Circ. Res. 101 (2007) 295-303
93. Song J., Cottler P.S., Klibanov A.L., Kaul S., and Price R.J. Microvascular remodeling and accelerated hyperemia blood flow restoration in arterially occluded skeletal muscle exposed to ultrasonic microbubble destruction. Am. J. Physiol. Heart Circ. Physiol. 287 (2004) H2754-H2761
94. Yoshida J., Ohmori K., Takeuchi H., Shinomiya K., Namba T., Kondo I., Kiyomoto H., and Kohno M. Treatment of ischemic limbs based on local recruitment of vascular endothelial growth factor-producing inflammatory cells with ultrasonic microbubble destruction. J. Am. Coll. Cardiol. 46 (2005) 899-905
95. Miyake Y., Ohmori K., Yoshida J., Ishizawa M., Mizukawa M., Yukiiri K., and Kohno M. Granulocyte colony-stimulating factor facilitates the angiogenesis induced by ultrasonic microbubble destruction. Ultrasound Med. Biol. 33 (2007) 1796-1804
96. Zen K., Okigaki M., Hosokawa Y., Adachi Y., Nozawa Y., Takamiya M., Tatsumi T., Urao N., Tateishi K., Takahashi T., and Matsubara H. Myocardium-targeted delivery of endothelial progenitor cells by ultrasound-mediated microbubble destruction improves cardiac function via an angiogenic response. J. Mol. Cell. Cardiol. 40 (2006) 799-809
97. Trubestein G., Engel C., Etzel F., Sobbe A., Cremer H., and Stumpff U. Thrombolysis by ultrasound. Clin. Sci. Mol. Med. Suppl 3 (1976) 697s-698s
98. Pfaffenberger S., Devcic-Kuhar B., Kastl S.P., Huber K., Maurer G., Wojta J., and Gottsauner-Wolf M. Ultrasound thrombolysis. Thromb. Haemost. 94 (2005) 26-36
99. Atar S., Luo H., Nagai T., Sahm R.A., Fishbein M.C., and Siegel R.J. Arterial thrombus dissolution in vivo using a transducer-tipped, high-frequency ultrasound catheter and local low-dose urokinase delivery. J. Endovasc. Ther. 8 (2001) 282-290
100. Singh M., Rosenschein U., Ho K.K., Berger P.B., Kuntz R., and Holmes Jr. D.R. Treatment of saphenous vein bypass grafts with ultrasound thrombolysis: A randomized study (atlas). Circulation 107 (2003) 2331-2336
101. Brosh D., Bartorelli A.L., Cribier A., Mesa J., Calderon L., Martyn T., Amann F., Sampaolesi A., Desmet W., Fajadet J., and Rosenschein U. Percutaneous transluminal therapeutic ultrasound for high-risk thrombus-containing lesions in native coronary arteries. Catheter. Cardiovasc. Interv. 55 (2002) 43-49
102. Porter T.R., LeVeen R.F., Fox R., Kricsfeld A., and Xie F. Thrombolytic enhancement with perfluorocarbon-exposed sonicated dextrose albumin microbubbles. Am. Heart J. 132 (1996) 964-968
103. Alexandrov A.V., Wojner A.W., and Grotta J.C. Clotbust: Design of a randomized trial of ultrasound-enhanced thrombolysis for acute ischemic stroke. J. Neuroimaging. 14 (2004) 108-112
104. Cohen M.G., Tuero E., Bluguermann J., Kevorkian R., Berrocal D.H., Carlevaro O., Picabea E., Hudson M.P., Siegel R.J., Douthat L., Greenbaum A.B., Echt D., Weaver W.D., and Grinfeld L.R. Transcutaneous ultrasound-facilitated coronary thrombolysis during acute myocardial infarction. Am. J. Cardiol. 92 (2003) 454-457
105. Motarjeme A. Ultrasound-enhanced thrombolysis. J. Endovasc. Ther. 14 (2007) 251-256
106. Feinstein S.B., Cheirif J., Ten Cate F.J., Silverman P.R., Heidenreich P.A., Dick C., Desir R.M., Armstrong W.F., Quinones M.A., and Shah P.M. Safety and efficacy of a new transpulmonary ultrasound contrast agent: Initial multicenter clinical results. J. Am. Coll. Cardiol. 16 (1990) 316-324
107. Rovai D., Lombardi M., Cini G., Morales M.A., Colonna M., Bechelli G., Marino P., Zanolla L., Prioli M.A., Nicolosi G.L., et al. Echocardiographic contrast imaging of the human right heart: A multicenter study of the efficacy, safety, and reproducibility of intravenous shu-454. J. Clin. Ultrasound 19 (1991) 523-530
108. Dalecki D., Raeman C.H., Child S.Z., Penney D.P., Mayer R., and Carstensen E.L. The influence of contrast agents on hemorrhage produced by lithotripter fields. Ultrasound Med. Biol. 23 (1997) 1435-1439
109. Miller D.L., and Gies R.A. Gas-body-based contrast agent enhances vascular bioeffects of 1.09 mhz ultrasound on mouse intestine. Ultrasound Med. Biol. 24 (1998) 1201-1208
110. Miller D.L., and Gies R.A. The influence of ultrasound frequency and gas-body composition on the contrast agent-mediated enhancement of vascular bioeffects in mouse intestine. Ultrasound Med. Biol. 26 (2000) 307-313
111. Miller D.L., and Quddus J. Diagnostic ultrasound activation of contrast agent gas bodies induces capillary rupture in mice. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 10179-10184
112. Kobayashi N., Yasu T., Yamada S., Kudo N., Kuroki M., Kawakami M., Miyatake K., and Saito M. Endothelial cell injury in venule and capillary induced by contrast ultrasonography. Ultrasound Med. Biol. 28 (2002) 949-956
113. Schlachetzki F., Holscher T., Koch H.J., Draganski B., May A., Schuierer G., and Bogdahn U. Observation on the integrity of the blood-brain barrier after microbubble destruction by diagnostic transcranial color-coded sonography. J. Ultrasound Med. 21 (2002) 419-429
114. Dalecki D., Raeman C.H., Child S.Z., Cox C., Francis C.W., Meltzer R.S., and Carstensen E.L. Hemolysis in vivo from exposure to pulsed ultrasound. Ultrasound Med. Biol. 23 (1997) 307-313
115. MacRobbie A.G., Raeman C.H., Child S.Z., and Dalecki D. Thresholds for premature contractions in murine hearts exposed to pulsed ultrasound. Ultrasound Med. Biol. 23 (1997) 761-765
116. Dalecki D., Raeman C.H., Child S.Z., and Carstensen E.L. Effects of pulsed ultrasound on the frog heart: Iii. The radiation force mechanism. Ultrasound Med. Biol. 23 (1997) 275-285
117. van Der Wouw P.A., Brauns A.C., Bailey S.E., Powers J.E., and Wilde A.A. Premature ventricular contractions during triggered imaging with ultrasound contrast. J. Am. Soc. Echocardiogr. 13 (2000) 288-294
118. Miller D.L., Driscoll E.M., Dou C., Armstrong W.F., and Lucchesi B.R. Microvascular permeabilization and cardiomyocyte injury provoked by myocardial contrast echocardiography in a canine model. J. Am. Coll. Cardiol. 47 (2006) 1464-1468
119. Li P., Armstrong W.F., and Miller D.L. Impact of myocardial contrast echocardiography on vascular permeability: Comparison of three different contrast agents. Ultrasound Med. Biol. 30 (2004) 83-91
120. Li P., Cao L.Q., Dou C.Y., Armstrong W.F., and Miller D. Impact of myocardial contrast echocardiography on vascular permeability: An in vivo dose response study of delivery mode, pressure amplitude and contrast dose. Ultrasound Med. Biol. 29 (2003) 1341-1349
121. Ay T., Havaux X., Van Camp G., Campanelli B., Gisellu G., Pasquet A., Denef J.F., Melin J.A., and Vanoverschelde J.L. Destruction of contrast microbubbles by ultrasound: effects on myocardial function, coronary perfusion pressure, and microvascular integrity. Circulation 104 (2001) 461-466
122. Chen S., Kroll M.H., Shohet R.V., Frenkel P., Mayer S.A., and Grayburn P.A. Bioeffects of myocardial contrast microbubble destruction by echocardiography. Echocardiography 19 (2002) 495-500
123. Borges A.C., Walde T., Reibis R.K., Grohmann A., Ziebig R., Rutsch W., Schimke I., and Baumann G. Does contrast echocardiography with optison induce myocardial necrosis in humans?. J. Am. Soc. Echocardiogr. 15 (2002) 1080-1086
124. Bekeredjian R., Chen S., Pan W., Grayburn P.A., and Shohet R.V. Effects of ultrasound-targeted microbubble destruction on cardiac gene expression. Ultrasound Med. Biol. 30 (2004) 539-543
125. Muller O.J., Kaul F., Weitzman M.D., Pasqualini R., Arap W., Kleinschmidt J.A., and Trepel M. Random peptide libraries displayed on adeno-associated virus to select for targeted gene therapy vectors. Nat. Biotechnol. 21 (2003) 1040-1046
126. Guo D.P., Li X.Y., Sun P., Wang Z.G., Chen X.Y., Chen Q., Fan L.M., Zhang B., Shao L.Z., and Li X.R. Ultrasound/microbubble enhances foreign gene expression in ecv304 cells and murine myocardium. Acta Biochim. Biophys. Sin. (Shanghai) 36 (2004) 824-831